近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
1.Yuan Zhang#, Fengjiang Wei#, Chen Chen#, ChunyouCai#, Kai Zhang, Ning Sun, JianliTian, Wentao Shi, Miaomiao Zhang, Yong Zang, Jiani Song, Yukun He, JiayiFeng, Qianqian Zhou, Mengyan Li, PufeiBai, ShuzhiFeng*, and Wei-Dong Li*. Higher triglyceride level predicts hyperuricemia: a prospective study of 6-year follow-up. Journal of Clinical Lipidology. 2017, in press.
2.Fengjiang Wei#, Ning Sun#, ChunyouCai#, ShuzhiFeng#, JianliTian, Wentao Shi, WeiliXu, Yaogang Wang*, Xilin Yang*, and Wei-Dong Li*. Associations between serum uric acid and the incidence of hypertension: A Chinese senior dynamic cohort study. Journal of Translational Medicine, 2016, 14:110.
3.Fengjiang Wei#, ChunyouCai#, ShuzhiFeng#, JiaLv, Shen Li, Baocheng Chang, Hong Zhang, Wentao Shi, Hongling Han, Chao Ling, Ping Yu, Yongjun Chen, Ning Sun, JianliTian, Hongxiao Jiao, Fuhua Yang, Mingshan Li, Yuhua Wang, Lei Zou, Long Su, Jingbo Li, Ran Li, HuinaQiu, Jingmin Shi, Shiying Liu, Mingqin Chang, Jingna Lin*, Liming Chen*, Wei-Dong Li* TOX and CDKN2A/B Gene Polymorphisms Are Associated with Type 2 Diabetes in Han Chinese. Scientific Reports, 2015, 5:11900
4.Shi WT#*, Cai CY#, Li MS#, Ling C, Li, WD*.Han Chinese patients with dopa-responsive dystonia exhibit a low frequency of exonic deletion in the GCH1 gene.Genetics and Molecular Research ,2015, 14(3):11185-11190.
5.Wei FJ#, Cai CY#, Yu P#, Lv J#, Ling C, Shi WT, Jiao HX, Chang BC, Yang FH, Tian Y, Li MS, Wang YH, Zou L, Shi JM, Chen LM*, Li WD*.Quantitative candidate gene association studies of metabolic traits in Han Chinese type 2 diabetes patients.Genet Mol Res. 2015 Dec 1;14(4):15471-81.
6.Cai C#, Shi W#, Zeng Z#, Zhang M, Ling C, Chen L, Cai C, Zhang B*, Li WD*.GTP cyclohydrolase I and tyrosine hydroxylase gene mutations in familial and sporadic dopa-responsive dystonia patients.PLoS One. 2013 Jun 6;8(6):e65215.
7.Cai CY#, Zhu H#, Shi W#, Su L#, Shi O, Cai CQ, Ling C, Li WD*.A novel splicing site mutation of the GPR143 gene in a Chinese X-linked ocular albinism pedigree.Genet Mol Res. 2013 Nov 18;12(4):5673-9.
8.蔡春友,付金瑞,姚智*.乳腺癌NF-κB、HER2、VEGF-C 与VEGFR3 表达及意义.中国肿瘤临床,2005,23:1333-1337.
9.蔡春友,张维铭*,孙保存,章明放,侯威,杨军谦.IL-1 对II 型胶原诱导建立RA 模型的影响.中华骨科杂志,1999,10:25-27.
10.蔡春友,张维铭*,刘霜,孙保存,于士柱,刘虹,杨军谦.PCR-ELISA 检测端粒酶活性及其应用.中国肿瘤临床,2000,27:14-16.
11.蔡春友,张维铭*,孙保存,于士柱,杨军谦.肺癌端粒酶活性与临床相关性.中国肿瘤临床,1999,26:462-463.
12.蔡春友,孙保存,于士柱,只达石*.神经上皮起源肿瘤端粒酶与PCNA 表达的关系.中华病理学杂志,1999,28:47-48.
13.蔡春友,只达石,于士柱,孙保存*.星形细胞起源肿瘤组织端粒酶活性研究.中华医学杂志,1998,78:563-563.吕佳, 蔡春友, 魏凤江, 张红, 林静娜, 韩鸿玲, 陈莉明, 李卫东*. TOX和SMAD3基因多态性与中国汉族人群2型糖尿病患者微血管病变的易感性相关. 天津医科大学学报, 2013, 19:9-12.
14.于萍, 蔡春友, 魏凤江, 凌超, 时文涛, 林静娜, 陈莉明, 李卫东*. MYH9和ABI2基因SNP在2型糖尿病人群中与血糖、胰岛素抵抗和血压的相关性. 天津医科大学学报, 2012 (1), 17-20.
15.魏凤江,蔡春友,时文涛,陈莉明,林静娜,于萍,凌超,李卫东*.2型糖尿病合并高尿酸血症与胰岛素抵抗、血脂及血压相关性的研究.中国糖尿病杂志,2013,21(2):44-46.